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Background and aim: Established anti-reﬂux procedures such as fundoplications are less
efﬁcient in obese patients. The aim of this study was to investigate clinical effectiveness of
the fundoplication combined with gastric greater curvature plication in the treatment of
gastroesophageal reﬂux disease (GERD) in obese patients.
Materials and methods: During the period from June 2010 to September 2014, patients
operated for GERD with BMI from 30 to 39.9 kg/m2 were included into the prospective study.
Laparoscopic Nissen fundoplication (LNF, n = 58) was performed until February 2013 and
later laparoscopic Nissen fundoplication was combined with gastric greater curvature
plication (LNFGP, n = 56). The groups were compared according to the control of GERD
and weight loss.
Results: In LNF group there were signiﬁcantly more males, patients had lower BMI and longer
duration of GERD symptoms. Duration of surgery was signiﬁcantly longer in LNFGP group,
96.5 (17.3) min vs. 59.8 (16.1) min (P < 0.0001). Postoperative morbidity was similar, 3.6% and
3.4% in LNFGP and LNF groups, respectively (P = 0.9539). The average percentage of excess
BMI loss after 12 months was 45.3 (5.8) in LNFGP group as compared to 18.4 (4.6) in LNF group
(P < 0.0001). Signiﬁcantly more patients experienced remission or improvement of type 2
diabetes mellitus (P = 0.03) and hypercholesterolemia (P = 0.0001) in LNFGP group. No sig-
niﬁcant differences between the groups in postoperative DeMeester score, GERD-HRQL
mean score, overall satisfaction and healing of esophagitis were observed.
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Conclusions: LNFGP took signiﬁcantly longer time to perform, but resulted in signiﬁcantly
higher weight reduction and remission/improvement of comorbidities. Both procedures
produced similar anti-reﬂux effect.
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The prevalence of gastroesophageal reﬂux disease (GERD) has
increased since 1995 and currently 10% to 30% of the adult
population in the world experiences at least weekly symptoms
such as heartburn and/or regurgitation [1]. One possible
explanation for the high prevalence of GERD could be globally
increasing rate of obesity, as there is evidence that overweight
and obese individuals suffer from GERD more often than
individuals with normal BMI [2,3]. Increased intra-abdominal
pressure in obese individuals may facilitate development of
gastroesophageal reﬂux as there is an established correlation
between GERD and waist circumference. This correlation was
found to be even greater than that between GERD and BMI [4].
However, the prevalence of GERD among individuals with
severe obesity is about 50% [5], what suggests that severe
obesity itself is not sufﬁcient to cause GERD, and that in at least
half of severely obese individuals physiological mechanisms
that prevent GERD remain reasonably intact. Hiatal hernias are
signiﬁcantly more prevalent among obese patients [6] and are
one of the main pathological mechanisms that cause GERD in
obese individuals.
The surgical treatment of GERD gives better short and
medium term results as compared to medical management [7].
For individuals with obesity and GERD, Roux-en-Y gastric
bypass (RYGB) is considered to be a procedure of choice [8].
However, RYGB is a rather complicated surgical intervention
with possible long-term nutritional consequences and not all
patients, especially with obesity of grade I or II, are willing to
undergo such an extensive procedure for their reﬂux symp-
toms. An ideal procedure should combine good reﬂux control
and result in weight loss, as weight loss itself has shown to
have beneﬁcial effect on reﬂux control [9]. Reﬂux control after
Nissen fundoplication is comparable to RYGB in obese patients
[10], but weight loss is much less. It would be reasonable to
suggest restrictive bariatric procedures such as sleeve gastr-
ectomy or adjustable gastric banding for GERD control as
metabolic consequences of these interventions are less when
compared to RYGB. However, up to 20% of the patients'
experiences de novo reﬂux symptoms after sleeve gastrecto-
my [11,12] and the popularity of adjustable gastric banding
decreases in the world because of high rate of late failures [13].
Recently a combination of Nissen fundoplication with
gastric greater curvature plication (GGCP) was suggested for
GERD control in obese patients [14]. No studies so far have
compared this type of procedure to a Nissen fundoplication
alone and thus the aim of the current study was to compare
the results of GERD control in obese patients after these two
procedures in the prospective trial.2. Materials and methods
All necessary ethical and governance approvals were obtained
from the Ethics Committee of the Medical University of Astana
(No. 3, January 15, 2010). Only adult patients with BMI 30–
39.9 kg/m2 and typical GERD symptoms were eligible for the
study. Exclusion criteria were refusal of the patient to
participate in the study, short esophagus (it was diagnosed
when after extensive mobilization of the esophagus gastro-
esophageal junction, identiﬁed during preoperative endosco-
py, could be located less than 1.5 cm below apex of the
diaphragmatic hiatus without any tension), giant hiatal hernia
and previous surgery in the gastroesophageal region.
The study was performed in the Surgical Departments of
Akmola Regional Hospital №2 and National Research Medical
Center in Astana, Kazakhstan, during the period from June
2010 to September 2014. A total of 120 consecutive patients
with GERD and BMI 30–39.9 kg/m2 were available for inclusion.
Six patients met exclusion criteria and thus ﬁnal number of
included patients was one hundred fourteen. All patients
signed informed consent. The study was divided into two
periods. From June 2010 to February 2013, 58 patients were
operated on with laparoscopic Nissen gastrofundoplication
(LNF) only. During the second period from February 2013 to
September 2014, 56 patients underwent laparoscopic Nissen
fundoplication combined with gastric greater curvature plica-
tion (LNFGP).
2.1. Clinical assessment
All patients had weight and height measured by scales and
stadiometer (Fazzini S7350HR, Italy) before operation, 6 and 12
months after operation. Weight outcomes are presented as
percentage of excess BMI loss (%EBMIL) and were estimated by
the formula: %EBMIL = (BMI loss/[baseline BMI  25])  100
[15].
All patients completed the Gastroesophageal Reﬂux Dis-
ease-Health Related Quality of Life (GERD-HRQL) [16] ques-
tionnaire before and 1 year after surgery. The questionnaire
included 11 items. Ten items were scored from 0 to 5 and were
used to calculate the overall score by simply adding the
individual values of the items. The last 11th item represents
overall patients' satisfaction.
2.2. Preoperative and postoperative investigations
Esophagogastroduodenoscopy (Evis Exera II Olympus CV-180,
Japan) was routinely performed in all patients preoperatively
and one year after surgery. The changes in esophageal mucosa
Fig. 2 – Cross-sectional view of calibration tube and
invaginated fold in the lumen of the stomach during gastric
greater curvature plication.
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classiﬁcation [17]. Barium meal X-ray test was done preopera-
tively to all patients in order to diagnose hiatal hernia and to
exclude patients with giant hernias. Postoperative investiga-
tion was performed only if GERD recurrence was suspected.
The 24-h monitoring of pH in the esophagus was performed
preoperatively and on average 7 month after operation for the
patients who agreed to undergo this investigation with the
portable device (AGM-24PM ‘‘Gastroscan-24’’, Russia). Patients
discontinued acid-reducing medications at least 1 week before
planned measurements. After placement of pH electrode the
patients were informed to follow their usual life activities. The
pH measurements were analyzed and DeMeester score
calculated [18].
2.3. Surgical interventions
All operations were done by laparoscopy. Calibration tube of
32–34 Fr. (Sumi, Poland) was placed in the lumen of the
esophagus and stomach. Ultrasonic shears (SonoSurg, Olym-
pus, Japan) were used to cut tissues and seal blood vessels.
Only fundal part of the stomach was mobilized, if Nissen
fundoplication alone was performed. In the case of combined
procedure, mobilization of the greater curvature of the
stomach was started 4–6 cm above the pyloric sphincter and
was performed all the way to the His angle (Fig. 1). All the
tissues around left diaphragmatic crus were dissected
completely and the presence of hiatal hernia was identiﬁed
by the inspection of hiatal region. If hiatal hernia was present,
as was the case in 95% of our patients, the right diaphragmatic
crus was approached through hepatogastric ligament. Metic-
ulous dissection was done in the hiatal region. Anterior and
posterior vagal nerves were identiﬁed and preserved. Posterior
cruroplasty was done with separate sutures. The esophagus
was then encircled with fundal part of the stomach andFig. 1 – Greater curvature mobilization. The arrows indicate
the beginning and the completion of the mobilization. The
dashed line indicates the direction of mobilization. 1, body
of the stomach; 2, greater curvature; 3, pylorus; 4, angle of
His; 5, gastric fundus; 6, right diaphragmatic crus; 7, left
diaphragmatic crus; 8, gastroesophageal junction.360 ﬂoppy Nissen fundoplication was performed. In all cases
non-absorbable seromuscular sutures were used and anterior
esophageal wall was included into the stitch. The length of the
wrap was less than 2 cm. If gastric greater curvature plication
was added to Nissen fundoplication, it was performed by two
layers of separate non-absorbable sutures (Ethibond 2/0)
placed with 1 cm intervals starting from the fundal part of
the stomach and ﬁnishing 4–5 cm above pylorus (Figs. 2 and 3).
2.4. Statistical analysis
Continuous variables are presented as mean (standard
deviation). Categorical variables are expressed as number
(percentage) of patients affected. Shapiro–Wilk test was used
to assess normality of the data. Comparison of mean values
with Student t test was performed in case of normal
distribution. Nonparametric statistics such as Mann–Whitney
U test was used to compare continuous variables with
abnormal distribution and ordinal variables. Categorical
variables were compared by the chi-square test. Signiﬁcant
difference was deﬁned as P < 0.05.
3. Results
Patients in LNF group had signiﬁcantly lower BMI, longer
duration of GERD symptoms and more patients were males as
compared to LNFGP group (Table 1). As expected, the average
duration of surgery was signiﬁcantly longer in LNFGP group,
but there was no difference in average hospital stay, morbidity
and mortality between the groups (Table 2). There were no
fatal outcomes in this study. Two perioperative complications
occurred in each group. In LNFGP group both patients had
bleeding. One from superﬁcial injury to the spleen during the
Fig. 3 – Nissen fundoplication combined with gastric great
curvature plication.
Table 3 – Data on 24-h pH measurement.
Indices Before operation 
LNFGP (n = 15) LNF (n = 15) 
1 2 
% Time with pH < 4 8.7 (0.7) 8.2 (0.8) 
P 0.0928 
Reﬂux episodes (pH < 4)/24 h 71.1 (11.7) 63.2 (23.7) 
P 0.2555 
Reﬂux episodes > 5 min/24 h 8.6 (2.2) 8.0 (0.9) 
P 0.3879 
DeMeester index 41.7 (4.9) 40.7 (3.5) 
P 0.5510 
Values are mean (standard deviation).
Table 2 – Perioperative data.
Characteristic LNFGP
(n = 56)
LNF
(n = 58)
P
Duration of operation,
min
96.5 (17.3) 59.8 (16.1) <0.0001
Postoperative
complications, n (%)
2 (3.6) 2 (3.4) 0.9539
Hospital stay, days 4.3 (0.5) 4.5 (1.0) 0.1159
Mortality, n (%) 0 (0) 0 (0) 1.000
Values are mean (standard deviation) unless otherwise indicated.
LNFGP, laparoscopic Nissen fundoplication with gastric greater
curvature plication; LNF, laparoscopic Nissen fundoplication.
Table 1 – General characteristics of the study population.
Characteristic LNFGP (n = 56) LNF (n = 58) P
Male/female, n (%) 7/49 (12.5/87.5) 24/34 (41.4/58.6) 0.0006
Age, years 43.8 (9.7) 46.3 (9.9) 0.17
BMI, kg/m2 36.6 (2.4) 35.2 (2.1) 0.0012
Waist circumference,
cm
85.5 (6.3) 87.5 (6.0) 0.0853
Duration of GERD
symptoms, years
6.9 (1.9) 7.6 (1.7) 0.04
Values are mean (standard deviation) unless otherwise indicated.
BMI, body mass index; GERD, gastroesophageal reﬂux disease;
LNFGP, laparoscopic Nissen fundoplication with gastric greater
curvature plication; LNF, laparoscopic Nissen fundoplication.
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tion. The other had postoperative bleeding from short gastric
vessels, which was controlled during re-laparoscopy. One
patient in LNF group had pneumothorax, which has resolved
after placement of chest tube and the other patient had
dysphagia due to tight fundoplication. The patient
was successfully treated by ﬂoppy Nissen re-fundoplication
7 weeks after primary surgery.
There was no difference in acid exposure in the esophagus
between the groups either before or after operations (Table 3).
However, acid exposure signiﬁcantly decreased within the
groups after operation. DeMeester generalized index de-
creased from 41.7 to 10.5 (P < 0.0001) in the LNFGP group
and from 40.7 to 11.3 (P < 0.0001) in the LNF group. Similarly,
the subjective complaints of the patients evaluated by GERD-
HRQL questionnaire signiﬁcantly improved in both groups
after surgery, but there was no difference in the mean score
between the groups (Table 4). The prevalence and the grade of
esophagitis decreased signiﬁcantly after surgery in both
groups (Table 5). Preoperatively all patients used proton pump
inhibitors (PPI) regularly. Four patients in the LNFGP group and
5 in the LNF group used PPI occasionally 1 year after surgery.
Moreover, the proportion of patients who were satisﬁed with
GERD control increased from 0% to 79% in the LNFGP group1 year after operation P (comparison
before and after
operation)
LNFGP (n = 15) LNF (n = 8)
3 4 1 and 3 2 and 4
3.5 (1.2) 3.3 (1.0) <0.0001 <0.0001
0.7418
20.8 (5.2) 18.8 (6.1) <0.0001 <0.0001
0.6093
1.9 (1.0) 2.2 (1.1) <0.0001 <0.0001
0.5044
10.5 (2.1) 11.3 (1.5) <0.0001 <0.0001
0.3419
Table 5 – Degree of esophagitis.
Indices Before operation 1 year after operation P (comparison before
and after operation)
LNFGP (n = 56) LNF (n = 58) LNFGP (n = 45) LNF (n = 48)
1 2 3 4 1 and 3 2 and 4
No esophagitis, n (%) 0 (0) 0 (0) 40 (88.9) 43 (89.5) < 0.0001 <0.0001
A 18 (32.1) 20 (34.4) 5 (11.1) 5 (10.4)
B 21 (37.5) 22 (37.9) 0 0
C 13 (23.2) 11 (19.0) 0 0
D 4 (7.1) 5 (8.6) 0 0
P 0.78716 0.96012
LNFGP, laparoscopic Nissen fundoplication with gastric greater curvature plication; LNF, laparoscopic Nissen fundoplication.
Table 4 – Results of GERD-HRQL.
Before operation 1 year after operation C (comparison
before and after
operation)
Criterion LFN + LGP (n = 56) LFN (n = 58) LFN + LGP (n = 55) LFN (n = 56)
1 2 3 4 1 and 3 2 and 4
GERD-HRQL score 15.1 (5.8) 14.5 (6.4) 2.0 (3.1) 2.1 (3.1) <0.0001 <0.0001
P 0.5774 0.8625
Heartburn sub score 2.7 (0.8) 2.9 (0.6) 0.39 (0.7) 0.22 (0.5) <0.0001 <0.0001
P 0.1759 0.1516
Satisfaction index, n (%)
Satisﬁed 0 0 43 (79) 46 (82) <0.0001 <0.0001
Neutral 5 (9) 10 (17) 9 (16) 6 (11)
Dissatisﬁed 51 (91) 48 (83) 3 (5) 4 (7)
P 0.42372 0.76418
Values are mean (standard deviation) unless otherwise indicated.
LNFGP, laparoscopic Nissen fundoplication with gastric greater curvature plication; LNF, laparoscopic Nissen fundoplication.
Fig. 4 – Boxplot showing the average percentage of excess
BMI loss (%EBMIL) 12 months after surgery in the
laparoscopic Nissen fundoplication with gastric greater
curvature plication (LNFGP) and laparoscopic Nissen
fundoplication (LNF) groups.
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(Table 4).
The %EBMIL 12 months after surgery was 45.26 (5.8) and
18.43 (4.6) in LNFGP and LNF groups, respectively (P < 0.0001)
(Fig. 4). More patients had remission or improvement of their
comorbidities associated with obesity in LNFGP group as
compared to LNF group (Table 6).
4. Discussion
Nissen fundoplication is a procedure of choice in the
treatment of patients with GERD, though some other types
of fundoplications (Toupet, Dor) were found to produce
comparable results [19,20]. The data about long-term effec-
tiveness of Nissen fundoplications in patients with obesity and
GERD are controversial [21,22]. Therefore, RYGB as a procedure
with durable weight loss and anti-reﬂux effects was proposed
for obese individuals with GERD. RYGB reduces severity of
reﬂux symptoms, reﬂuxesophagitis as well as oesophageal
acid exposure [23] and 56% of the patients do not need acid
reducing medications one-year after surgery [24]. Further-
more, laparoscopic RYGB could be performed as safe as
laparoscopic fundoplication with comparable morbidity, mor-
tality and hospital costs [25].
Table 6 – Comorbidity status before and 1 year after operations.
Type 2 diabetes mellitus Hypertension Hyper-cholesterolemia
LNFGP (n = 51) LNF (n = 44) P LNFGP (n = 51) LNF (n = 44) P LNFGP (n = 51) LNF (n = 44) P
Before operation, n (%) 5 (9.8) 5 (11.4) 0.8011 10 (19.6) 6 (13.6) 0.4381 12 (23.5) 15 (34.1) 0.2558
After operation, n (%) 0.0285 0.3576 0.0001
Remission 2 (40) 0 2 (20) 0 7 (58.3) 0
Improvement 3 (60) 1 (20) 5 (50) 3 (50) 5 (41.7) 4 (26.7)
Stable/worse 0 4 (80) 3 (30) 3 (50) 0 11 (73.3)
LNFGP, laparoscopic Nissen fundoplication with gastric greater curvature plication; LNF, laparoscopic Nissen fundoplication
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anti-acid medications before RYGB start using them one-year
after surgery [24]. The reason for this is unknown, but could be
partially explained by the presence of untreated hiatal hernias.
The intraoperative inspection for a hiatal hernia based on
laparoscopic visualization can be misleading. The preopera-
tive upper gastrointestinal contrast studies show that nearly
40% of morbidly obese patients have hiatal hernias [26], but
little data exist about the effect of hiatal hernia repair on the
long-term outcome of GERD after RYGB [27]. Currently, hiatal
hernia repair is not a routine procedure in patients with GERD
and obesity undergoing RYGB. Moreover, some patients after
RYGB experiences long-term consequences such as nutritional
deﬁciencies, marginal ulcers, internal hernias, dumping and
hypoglycemia, which can affect quality of life and needs
additional treatment. The patients without metabolic con-
sequences of obesity and with lower BMI maybe willing to
undergo the operation that can have a similarly good control of
the reﬂux with less weight loss and consequently less
metabolic derangements as in the case with RYGB.
Recently, Nissen fundoplication in combination with GGCP
was proposed as a treatment option for patients with GERD
and obesity [14,28]. Nissen fundoplication was found to reduce
reﬂux symptoms and acid exposure in the esophagus similarly
to RYGB in morbidly obese patients with GERD [10]. GGCP for
the treatment of morbid obesity was suggested by Tretbar et al.
in 1976 [29] and was thought to be an alternative to more
complicated bariatric procedures. It was based on the
observation that anti-reﬂux surgery results in weight loss
and the technique was an extension of the fundoplication by
invaginating the minor curvature all the way until the
‘‘incisura angularis’’ of the stomach. Wilkinson and Peloso
[30] used mesh to reinforce Tretbar plication. However, the use
of mesh increased risk for stomach perforation and despite
good weight loss results the technique was abandoned.
Modern GGCP was developed by Iranian surgeons Talebpour
and Amoli [31] who published the results of ﬁrst 100 patients
with %EWL of 60–61% after 12–24 months of follow-up.
However, the systemic review of 14 studies with 1450 patients
after GGCP have found large variation in %EWL (from 31.8% to
74.4%) after 6 to 24 month follow-up and concluded that it is
unclear, if the results are durable [32].
In the present study we compared Nissen fundoplication
combined with GGCP to Nissen fundoplication alone. This was
a prospective study divided into two periods. Signiﬁcantly
more male patients were operated with Nissen fundoplication
alone. Staehelin et al. [33] examined 1650 patients afterlaparoscopic fundoplication and found that male patients had
less dysphagia, better heartburn control and higher overall
satisfaction as compared to female patients. Higher preva-
lence of male patients in LNF group may have inﬂuenced the
results of GERD-HRQL score as it is based on subjective
patients' complaints. There is little evidence about gender
inﬂuence on the results of objective investigations such as 24-
h pH-metry. Vega et al. [34] have shown that males without
GERD or reﬂux symptoms had signiﬁcantly more reﬂux
episodes, total reﬂux time and % time with pH < 4 in the
distal esophagus than females. However, in this study
endoscopy was not performed to rule out hiatal hernia or
silent esophagitis, which could have had direct inﬂuence on
the obtained results. In our study preoperatively all patients
had esophagitis and 95% had hiatal hernia. Moreover, there
was no difference in acid exposure between groups measured
by 24-h pH-metry. Thus we assumed that groups were
comparable regarding GERD status and obesity. Both proce-
dures achieved good reﬂux control as proved by normalization
of DeMeester score, signiﬁcant decrease in GERD-HRQL mean
scores, increase in overall satisfaction and healing of esopha-
gitis in 90% of cases.
In our study Nissen fundoplication combined with GGCP
was a safe procedure with low morbidity. In contrast, Lee et al.
[14] reported 8% risk of major perioperative complications
after this procedure. Two patients in their series needed
revision sleeve gastrectomy for leakage and intraabdominal
abscess. Only one patient (1.7%) in the present study had
serious complication, which needed re-laparoscopy. The %
EBMIL of 45.3 was in a range of those reported after usual GGCP
[32]. All patients with type 2 diabetes mellitus and hypercho-
lesterolemia, and 70% of patients with hypertension experi-
enced remission or improvement of their comorbidities after
combined procedure. However, small number of patients with
co-morbidities in both groups prompts cautious evaluation of
these results. As GGCP is mainly a restrictive procedure the
effect on comorbidities should be attributed to weight loss
achieved after this procedure. Patients after Nissen fundo-
plication also lost weight, however, signiﬁcantly less as
compared to combined procedure. Similar weight loss after
Nissen fundoplication was previously reported in the liter-
ature [35].
Several limitations of this study should be addressed. First,
it was a prospective, but a nonrandomized study. Initially it
was planned as a study to explore efﬁciency of Nissen
fundoplication in the treatment of obese patients with GERD.
After gaining more experience with GGCP the decision was
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design may have created a selection bias with higher male
prevalence and potentially better clinical results in LNF group.
In such case 24 h pH-metry may allow more precise compari-
son of acid control after the procedures. However, it must be
admitted that pH-metry investigations in our study were done
only for 25% of patients preoperatively and even less
postoperatively. Signiﬁcant decrease in esophageal acid
exposure was found after operations within the groups.
However, comparison of acid exposure between the groups,
especially due to lower number of patients in LNF group
postoperatively, should be evaluated with caution. More data
are needed about acid control after combined procedure. GGCP
itself may increase intra-gastric pressure and facilitate
development of reﬂux similarly to sleeve gastrectomy. It is
still to be proven in future studies that complementary Nissen
fundoplication is able to counteract the mechanisms that
increase the risk of the reﬂux after GGCP. Second, the
observation time in this study was short. More information
is needed about durability of weight loss after combined
procedure. Weight regain may have a negative impact on the
status of comorbidities and reduce the positive effect of
combined procedure. If weight loss will be durable then
patients may have a lower intraabdominal pressure and
consequently the expected failure rate of anti-reﬂux procedure
may decrease giving some advantage to combined procedure
on long-term follow-up. Finally, a new procedure has to be
compared to RYGB, which is currently a procedure of choice for
obese patients with GERD. Future randomized controlled
studies may give a better insight into the role of this novel
procedure in the treatment of obese patients, at least with
grade I or II obesity.
5. Conclusions
Nissen fundoplication with GGCP took signiﬁcantly longer
time to perform, but resulted in signiﬁcantly higher weight
reduction and remission or improvement of comorbidities.
Both procedures produced similar anti-reﬂux effect.
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